HK Stock MarketDetailed Quotes

CLOVER BIO-B (02197)

Watchlist
  • 2.970
  • -0.090-2.94%
Not Open Apr 24 16:06 CST
3.86BMarket Cap-16.97P/E (TTM)

CLOVER BIO-B (02197) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Turnover
-90.88%3.51M
132.22%3.25M
-2.13%38.42M
-4,029.96%-10.1M
--39.26M
--257K
----
----
----
----
Operating income
-90.88%3.51M
132.22%3.25M
-2.13%38.42M
-4,029.96%-10.1M
39.26M
257K
Cost of sales
95.46%-765K
-143.58%-770K
-12.17%-16.84M
974.75%1.77M
---15.01M
---202K
----
----
----
----
Operating expenses
95.46%-765K
-143.58%-770K
-12.17%-16.84M
974.75%1.77M
-15.01M
-202K
Gross profit
-87.30%2.74M
129.81%2.48M
-10.99%21.58M
-15,250.91%-8.33M
24.24M
55K
Selling expenses
74.27%-5.07M
26.50%-4.91M
64.02%-19.71M
70.31%-6.68M
---54.77M
---22.51M
----
----
----
----
Administrative expenses
11.76%-66.33M
30.64%-29.18M
62.19%-75.17M
61.56%-42.08M
51.54%-198.82M
51.42%-109.47M
-18.67%-410.24M
---225.34M
-352.33%-345.71M
-348.66%-76.43M
Research and development expenses
0.57%-182.34M
15.31%-83.25M
71.78%-183.39M
74.51%-98.3M
55.65%-649.89M
54.91%-385.6M
19.77%-1.47B
---855.27M
-700.24%-1.83B
-398.31%-228.22M
Revaluation surplus
----
----
----
----
----
----
----
----
-537.09%-3.81B
-6,564.67%-597.66M
-Changes in the fair value of other assets
----
----
----
----
----
----
----
----
-537.09%-3.81B
-6,564.67%-597.66M
Special items of operating profit
107.22%46.29M
-78.58%13.84M
-184.41%-640.99M
-94.52%64.61M
233.13%759.41M
2,313.70%1.18B
-1,905.81%-570.41M
---53.3M
-273.30%-28.44M
-149.67%-7.62M
Operating profit
77.19%-204.72M
-11.28%-101.02M
-649.21%-897.67M
-113.71%-90.78M
95.10%-119.82M
158.42%662.37M
59.29%-2.45B
-1.13B
-560.28%-6.01B
-2,278.83%-909.93M
Financing cost
93.45%-377K
94.29%-248K
69.26%-5.76M
63.04%-4.34M
-215.73%-18.72M
-439.69%-11.75M
27.82%-5.93M
---2.18M
-176.35%-8.22M
71.23%-2.97M
Earning before tax
77.30%-205.09M
-6.46%-101.27M
-552.11%-903.43M
-114.62%-95.12M
94.35%-138.54M
157.27%650.62M
59.25%-2.45B
-1.14B
-559.03%-6.02B
-1,779.05%-912.9M
After-tax profit from continuing operations
77.30%-205.09M
-6.46%-101.27M
-552.11%-903.43M
-114.62%-95.12M
94.35%-138.54M
157.27%650.62M
59.25%-2.45B
-1.14B
-559.03%-6.02B
-1,779.05%-912.9M
Earning after tax
77.30%-205.09M
-6.46%-101.27M
-552.11%-903.43M
-114.62%-95.12M
94.35%-138.54M
157.27%650.62M
59.25%-2.45B
-1.14B
-559.03%-6.02B
-1,779.05%-912.9M
Profit attributable to shareholders
77.30%-205.09M
-6.46%-101.27M
-552.11%-903.43M
-114.62%-95.12M
94.35%-138.54M
157.27%650.62M
59.25%-2.45B
-1.14B
-559.03%-6.02B
-1,779.05%-912.9M
Basic earnings per share
77.78%-0.16
0.00%-0.08
-554.55%-0.72
-115.38%-0.08
95.05%-0.11
149.52%0.52
82.95%-2.22
-1.05
-398.85%-13.02
-169.07%-2.61
Diluted earnings per share
77.78%-0.16
0.00%-0.08
-554.55%-0.72
-115.38%-0.08
95.05%-0.11
149.52%0.52
82.95%-2.22
-1.05
-398.85%-13.02
-169.07%-2.61
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
--
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Auditor
Rongcheng (Hong Kong) Certified Public Accountants Limited
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
Ernst & Young
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020
Turnover -90.88%3.51M132.22%3.25M-2.13%38.42M-4,029.96%-10.1M--39.26M--257K----------------
Operating income -90.88%3.51M132.22%3.25M-2.13%38.42M-4,029.96%-10.1M39.26M257K
Cost of sales 95.46%-765K-143.58%-770K-12.17%-16.84M974.75%1.77M---15.01M---202K----------------
Operating expenses 95.46%-765K-143.58%-770K-12.17%-16.84M974.75%1.77M-15.01M-202K
Gross profit -87.30%2.74M129.81%2.48M-10.99%21.58M-15,250.91%-8.33M24.24M55K
Selling expenses 74.27%-5.07M26.50%-4.91M64.02%-19.71M70.31%-6.68M---54.77M---22.51M----------------
Administrative expenses 11.76%-66.33M30.64%-29.18M62.19%-75.17M61.56%-42.08M51.54%-198.82M51.42%-109.47M-18.67%-410.24M---225.34M-352.33%-345.71M-348.66%-76.43M
Research and development expenses 0.57%-182.34M15.31%-83.25M71.78%-183.39M74.51%-98.3M55.65%-649.89M54.91%-385.6M19.77%-1.47B---855.27M-700.24%-1.83B-398.31%-228.22M
Revaluation surplus ---------------------------------537.09%-3.81B-6,564.67%-597.66M
-Changes in the fair value of other assets ---------------------------------537.09%-3.81B-6,564.67%-597.66M
Special items of operating profit 107.22%46.29M-78.58%13.84M-184.41%-640.99M-94.52%64.61M233.13%759.41M2,313.70%1.18B-1,905.81%-570.41M---53.3M-273.30%-28.44M-149.67%-7.62M
Operating profit 77.19%-204.72M-11.28%-101.02M-649.21%-897.67M-113.71%-90.78M95.10%-119.82M158.42%662.37M59.29%-2.45B-1.13B-560.28%-6.01B-2,278.83%-909.93M
Financing cost 93.45%-377K94.29%-248K69.26%-5.76M63.04%-4.34M-215.73%-18.72M-439.69%-11.75M27.82%-5.93M---2.18M-176.35%-8.22M71.23%-2.97M
Earning before tax 77.30%-205.09M-6.46%-101.27M-552.11%-903.43M-114.62%-95.12M94.35%-138.54M157.27%650.62M59.25%-2.45B-1.14B-559.03%-6.02B-1,779.05%-912.9M
After-tax profit from continuing operations 77.30%-205.09M-6.46%-101.27M-552.11%-903.43M-114.62%-95.12M94.35%-138.54M157.27%650.62M59.25%-2.45B-1.14B-559.03%-6.02B-1,779.05%-912.9M
Earning after tax 77.30%-205.09M-6.46%-101.27M-552.11%-903.43M-114.62%-95.12M94.35%-138.54M157.27%650.62M59.25%-2.45B-1.14B-559.03%-6.02B-1,779.05%-912.9M
Profit attributable to shareholders 77.30%-205.09M-6.46%-101.27M-552.11%-903.43M-114.62%-95.12M94.35%-138.54M157.27%650.62M59.25%-2.45B-1.14B-559.03%-6.02B-1,779.05%-912.9M
Basic earnings per share 77.78%-0.160.00%-0.08-554.55%-0.72-115.38%-0.0895.05%-0.11149.52%0.5282.95%-2.22-1.05-398.85%-13.02-169.07%-2.61
Diluted earnings per share 77.78%-0.160.00%-0.08-554.55%-0.72-115.38%-0.0895.05%-0.11149.52%0.5282.95%-2.22-1.05-398.85%-13.02-169.07%-2.61
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --------Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified Opinion
Auditor Rongcheng (Hong Kong) Certified Public Accountants Limited--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More